Metoprolol: Applicability in Young Hypertensives in India Dr. Debopriyo Mondal11 Nov 2024 12:31 PM ISTHypertension affects 1 in 8 adults aged between 20 and 40 years. The prevalence of hypertension among adults in India is about 25 to 42% and three...
CVD Care Continuum in 2024: Metoprolol Revisited Dr Johann Christopher25 Oct 2024 11:02 AM ISTCoronary artery disease (CAD) is a significant group within cardiovascular diseases (CVD) that results from decreased myocardial perfusion, leading to...
World Heart Day- Revisiting Metoprolol's Contribution to Cardiology MDTV Bureau30 Sept 2024 8:45 AM ISTThis month, on September 29, 2024, as we celebrate World Heart Day, lets dive into the contribution of an age-old and trusted molecule Metoprolol,...
NPPA Revises Ceiling Price of 4 Scheduled Formulation, Detail Dr. Divya Colin23 Aug 2024 6:00 PM ISTNew Delhi: Through a recent notice, after considering the Wholesale Price Index (WPI) impact at 0.00551% for the year 2024, the National...
Metoprolol: 20-Year Journey Down the Memory Lane Dr K. Sarat Chandra22 July 2024 12:30 PM ISTIntroduction (1-2)Over the past two decades, metoprolol has established its position in managing cardiovascular diseases. As a beta-1 selective...
Cherishing the 100th Birth Anniversary of Sir James Wyte Black-Pioneer of the First Clinically Significant Beta-Blocker Dr Vilas P. Magarkar14 Jun 2024 11:15 AM ISTThe 100th birth anniversary of Sir James Wyte Black is a momentous occasion to reflect on his monumental contributions to medicine, particularly...
Hypertension Management in Pre- and Post- Percutaneous Coronary Intervention - An Expert Opinion MD Brand Connect10 Jun 2024 11:00 AM ISTAngiotensin receptor blockers (ARBs) are the most preferred antihypertensive agents among Indian cardiologists for managing hypertension in...
Beta Blockers: A Five-Decade Legacy and Spotlight on Metoprolol Dr. Rajiv Karnik17 May 2024 11:00 AM ISTSince their introduction over five decades ago, beta-blockers have revolutionized the landscape of cardiovascular medicine. Initially developed to...
Submit Source Data of Phase III CT Report: CDSCO Panel Tells Eris Lifesciences on Metoprolol Succinate plus Dapagliflozin FDC Dr. Divya Colin11 May 2024 6:00 PM ISTNew Delhi: Reviewing the Phase III clinical trial report of fixed-dose combination (FDC) drug, Metoprolol Succinate sustained released 25mg/50mg plus...
Diltiazem use tied to serious bleeding risk in atrial fibrillation patients on apixaban or rivaroxaban: JAMA Medha Baranwal26 April 2024 9:45 AM ISTUSA: A recent study published in the Journal of the American Medical Association (JAMA) has revealed an increased risk of serious bleeding compared...
IPC flags ADR linked to Nimesulide, Cefuroxime, Dutasteride plus Tamsulosin and some beta-blockers Roshni Dhar15 April 2024 5:30 PM ISTThe Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert, has revealed adverse drug reactions linked with the popular...
Health Bulletin 15/ April/ 2024 Roshni Dhar15 April 2024 4:36 PM ISTHere are the top health stories for the day:Three private hospitals in Telangana served notices sue to high c-section ratesThe Health Department...
